Master ReVasca Monograph 6.2.24 - Paper - Page 9
REVASCA™ PHYSICIAN MONOGRAPH
— Who Can Benefit from ReVasca™? —
Individuals who can benefit from taking ReVasca™ include:
Trauma or surgery patients
levels of inflammatory markers, i.e.
hsCRP,homocysteine, oxLDL, LDLP, ApoB,
Lp(a), MMP, MPV
High cardiovascular disease risk, including
hypertension, atherosclerosis, stroke, MI
Severe bacterial infections (sepsis) and
viral infections (including SARS-CoV-2)
Type 2 diabetes and insulin resistance
(pre-diabetes)
Poor immunity
The aging population
Heavy exercisers, athletes
Chronic Kidney Disease (CKD)
Patients with chronic inflammation and high
People wanting to improve endurance
and performance
— ReVasca™ Summary —
Protection of the endothelial glycocalyx (eCGX) is one of the most significant choices a practitioner can
make for a patient to improve their overall health and longevity.
Recommending ReVasca™ is an important step in protecting the eGCX and keep it functioning properly, through improved repair and regulation, improved nitric oxide production, improved immune
system, and decreased oxidative stress.
To review, the benefits of ReVasca™ include protection and support against:
Breakdown of glycocalyx by heparinase
Chronic Inflammation (metaflammation)
Cardiovascular issues
Issues with diabetes including diabetic
neuropathy
Kidney disease
COVID-19 (SARS CoV-2 infection) and
other viruses
Immune dysfunction
Poor wound healing